News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
490,787 Results
Type
Article (47470)
Company Profile (33)
Press Release (443284)
Section
Business (139329)
Career Advice (1173)
Deals (26351)
Drug Delivery (81)
Drug Development (63674)
Employer Resources (92)
FDA (12824)
Job Trends (11300)
News (247178)
Policy (25574)
Tag
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (6)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (1)
2024 Pharm Country Digital (1)
2024 Pharm Country Standard (1)
2025 Lone Star Bio Digital (1)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 Biotech Bay Standard (1)
2026 Pharm Country Premier (1)
Academia (2708)
Academic (1)
Accelerated approval (2)
Adcomms (14)
Allergies (61)
Alliances (33965)
ALS (59)
Alzheimer's disease (1130)
Antibody-drug conjugate (ADC) (84)
Approvals (12829)
Artificial intelligence (142)
Autoimmune disease (10)
Automation (7)
Bankruptcy (272)
Best Places to Work (9077)
BIOSECURE Act (16)
Biosimilars (72)
Biotechnology (30)
Bladder cancer (45)
Brain cancer (24)
Breast cancer (197)
Cancer (1492)
Cardiovascular disease (112)
Career advice (956)
Career pathing (14)
CAR-T (115)
Cell therapy (299)
Cervical cancer (14)
Clinical research (51486)
Collaboration (535)
Compensation (125)
Complete response letters (23)
COVID-19 (2341)
CRISPR (23)
C-suite (148)
Cystic fibrosis (71)
Data (1490)
Decentralized trials (1)
Denatured (11)
Depression (29)
Diabetes (183)
Diagnostics (4969)
Digital health (9)
Diversity (7)
Diversity, equity & inclusion (29)
Drug discovery (70)
Drug pricing (76)
Drug shortages (16)
Duchenne muscular dystrophy (57)
Earnings (52284)
Editorial (18)
Employer branding (11)
Employer resources (81)
Events (59235)
Executive appointments (516)
FDA (13644)
Featured Employer (13)
Friedreich's ataxia (1)
Frontotemporal dementia (6)
Funding (443)
Gene editing (63)
Generative AI (13)
Gene therapy (182)
GLP-1 (492)
Government (3469)
Grass and pollen (3)
Guidances (40)
Healthcare (14745)
Huntington's disease (14)
IgA nephropathy (16)
Immunology and inflammation (69)
Indications (23)
Infectious disease (2438)
Inflammatory bowel disease (106)
Inflation Reduction Act (8)
Influenza (37)
Intellectual property (63)
Interviews (188)
IPO (13245)
IRA (27)
Job creations (2538)
Job search strategy (838)
Kidney cancer (9)
Labor market (18)
Layoffs (349)
Leadership (5)
Legal (6389)
Liver cancer (54)
Lung cancer (228)
Lymphoma (103)
Machine learning (1)
Management (25)
Manufacturing (208)
MASH (50)
Medical device (9977)
Medtech (9979)
Mergers & acquisitions (13483)
Metabolic disorders (453)
Multiple sclerosis (54)
NASH (14)
Neurodegenerative disease (55)
Neuropsychiatric disorders (16)
Neuroscience (1483)
NextGen: Class of 2025 (4906)
Non-profit (3553)
Northern California (1627)
Now hiring (16)
Obesity (224)
Opinion (87)
Ovarian cancer (59)
Pain (63)
Pancreatic cancer (60)
Parkinson's disease (96)
Partnered (15)
Patents (155)
Patient recruitment (68)
Peanut (39)
People (44666)
Pharmaceutical (13)
Pharmacy benefit managers (17)
Phase I (15400)
Phase II (22729)
Phase III (17619)
Pipeline (717)
Podcasts (18)
Policy (79)
Postmarket research (1933)
Preclinical (6501)
Press Release (42)
Prostate cancer (72)
Psychedelics (25)
Radiopharmaceuticals (199)
Rare diseases (250)
Real estate (4479)
Recruiting (36)
Regulatory (17250)
Reports (26)
Research institute (1997)
Resumes & cover letters (195)
Rett syndrome (3)
RNA editing (1)
RSV (30)
Schizophrenia (50)
Series A (67)
Series B (37)
Service/supplier (5)
Sickle cell disease (39)
Southern California (1424)
Special edition (10)
Sponsored (20)
Startups (2372)
State (2)
Stomach cancer (8)
Supply chain (40)
The Weekly (7)
United States (14554)
Vaccines (553)
Venture capitalists (17)
Webinars (10)
Weight loss (152)
Women's health (22)
Worklife (4)
Date
Last 7 days (488)
Last 30 days (1954)
Last 365 days (26145)
2025 (4401)
2024 (27200)
2023 (30946)
2022 (38263)
2021 (44308)
2020 (43065)
2019 (34710)
2018 (26739)
2017 (24710)
2016 (22783)
2015 (27267)
2014 (19920)
2013 (16805)
2012 (17897)
2011 (18542)
2010 (16785)
Location
Africa (527)
Alabama (42)
Alaska (5)
Arizona (107)
Arkansas (11)
Asia (29681)
Australia (5103)
California (3698)
Canada (1458)
China (319)
Colorado (197)
Connecticut (197)
Delaware (75)
Europe (62926)
Florida (626)
Georgia (129)
Idaho (40)
Illinois (364)
India (13)
Indiana (212)
Iowa (5)
Japan (106)
Kansas (83)
Kentucky (17)
Louisiana (6)
Maine (48)
Maryland (543)
Massachusetts (2524)
Michigan (155)
Minnesota (206)
Mississippi (2)
Missouri (55)
Montana (26)
Nebraska (14)
Nevada (51)
New Hampshire (53)
New Jersey (1193)
New Mexico (15)
New York (1180)
North Carolina (675)
North Dakota (3)
Northern California (1627)
Ohio (125)
Oklahoma (12)
Oregon (18)
Pennsylvania (892)
Puerto Rico (5)
Rhode Island (18)
South America (789)
South Carolina (11)
South Dakota (1)
Southern California (1424)
Tennessee (74)
Texas (615)
Utah (118)
Virginia (101)
Washington D.C. (42)
Washington State (406)
West Virginia (3)
Wisconsin (25)
490,787 Results for "louisiana state university".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Solis Mammography Announces Acquisition of Breast Center of Acadiana in South Louisiana
October 10, 2024
·
2 min read
Drug Development
ASPIRE-FTD Phase 1/2 Clinical Trial Opens in the U.S. at The Ohio State University Wexner Medical Center
AviadoBio today announced that its Phase 1/2 ASPIRE-FTD clinical trial is now open and recruiting patients in the United States at The Ohio State University.
July 1, 2024
·
7 min read
Business
QIAGEN announces partnership with Penn State University to advance microbiome sciences
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a first-in-kind collaboration with Penn State University in the United States to create a shared research and education facility for the fast-developing microbiome sciences.
January 25, 2024
·
9 min read
Oncolytics Biotech® Announces Presentation at the Cancer Advocacy Group of Louisiana’s 3rd Annual NeauxCancer Conference
Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a clinical-stage immunotherapeutics company focused on oncology, today announced that Chief Executive Officer Dr. Matt Coffey will present a corporate overview at the Cancer Advocacy Group of Louisiana’s 3rd Annual NeauxCancer Conference.
February 28, 2024
·
2 min read
Drug Development
The Chilling Effect: State Actions, Patient Data Vulnerability, and DEI Uncertainty
In the current legal and political landscape, it is all about survival for DEI initiatives.
March 3, 2025
·
1 min read
Press Releases
QHSLab (OTCQB:USAQ) and South Dakota State University Celebrate NSF Invitation to Submit STTR Application for AIR-GUIDDE Technology
December 13, 2024
·
5 min read
Pharm Country
PAVmed Subsidiary, Veris Health, Announces Launch of Pilot Program with The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
PAVmed Inc announced that Veris and The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, a National Cancer Institute-Designated Comprehensive Cancer Center, launched a pilot program and enrolled the first patients on the Veris Cancer Care Platform™ pursuant to a recently-executed memorandum of understanding.
June 13, 2024
·
5 min read
Press Releases
Biocon Biologics and Civica, Inc. Collaborate to Expand Insulin Aspart Access in the United States
March 7, 2025
·
6 min read
Pharm Country
Halberd and Mississippi State University to Commence Stage II Advanced TBI Nasal Spray Testing
Halberd Corporation’s Traumatic Brain Injury mitigating nasal spray testing protocols at Mississippi State University were approved by the Institutional Animal Care and Use Committee.
February 8, 2024
·
3 min read
Press Releases
Biocon Biologics Launches Yesintek™ (ustekinumab-kfce) Biosimilar to Stelara® in the United States
February 24, 2025
·
8 min read
1 of 49,079
Next
